Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

New hair loss treatments show promise, but more research is needed to confirm their effectiveness.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

p14ARF and p16Ink4a cause hair follicle stem cell aging and dysfunction.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Cannabis may help with skin and hair health but could also increase heart and stroke risks.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Minoxidil effectively treats female pattern hair loss.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Apremilast shows promise for several skin conditions but needs more research.